Amyotrophic lateral sclerosis

Cumara B. O'Carroll, Amelia K. Adcock, Bart M Demaerschalk

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Motor neuron disorders encompass a group of neurodegenerative conditions in which the premature loss of motor neurons is the essential pathological feature. Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) in the United Kingdom, is the most common of these conditions. The major current therapeutic issues in ALS/MND are summarized in this chapter. The chapter examines whether pharmacological treatments prolong survival in patients with possible or definite ALS/MND. It explains how long-term mechanical ventilation (LTMV) affects survival and quality of life (QoL) in patients with ALS/MND with respiratory insufficiency. The chapter also examines how feeding gastrostomy improves nutritional state and probability of survival in patients with ALS/MND with bulbar involvement. The symptomatic treatments available for patients with ALS/MND are also covered in the chapter. The chapter finally analyzes whether multidisciplinary care (MDC) is an effective means of symptomatic and supportive management in patients with ALS/MND.

Original languageEnglish (US)
Title of host publicationEvidence-Based Neurology
Subtitle of host publicationManagement of Neurological Disorders: Second Edition
PublisherWiley Blackwell
Pages219-234
Number of pages16
ISBN (Electronic)9781119067344
ISBN (Print)9780470657782
DOIs
StatePublished - Dec 11 2015

Fingerprint

Amyotrophic Lateral Sclerosis
Motor Neurons
Survival
Motor Neuron Disease
Gastrostomy
Artificial Respiration
Respiratory Insufficiency
Therapeutics
Quality of Life
Pharmacology

Keywords

  • Amyotrophic lateral sclerosis
  • Feeding gastrostomy
  • Invasive assisted ventilation
  • Long-term mechanical ventilation
  • Motor neuron disease
  • Multidisciplinary care
  • Noninvasive positive pressure ventilation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

O'Carroll, C. B., Adcock, A. K., & Demaerschalk, B. M. (2015). Amyotrophic lateral sclerosis. In Evidence-Based Neurology: Management of Neurological Disorders: Second Edition (pp. 219-234). Wiley Blackwell. https://doi.org/10.1002/9781119067344.ch21

Amyotrophic lateral sclerosis. / O'Carroll, Cumara B.; Adcock, Amelia K.; Demaerschalk, Bart M.

Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, 2015. p. 219-234.

Research output: Chapter in Book/Report/Conference proceedingChapter

O'Carroll, CB, Adcock, AK & Demaerschalk, BM 2015, Amyotrophic lateral sclerosis. in Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, pp. 219-234. https://doi.org/10.1002/9781119067344.ch21
O'Carroll CB, Adcock AK, Demaerschalk BM. Amyotrophic lateral sclerosis. In Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell. 2015. p. 219-234 https://doi.org/10.1002/9781119067344.ch21
O'Carroll, Cumara B. ; Adcock, Amelia K. ; Demaerschalk, Bart M. / Amyotrophic lateral sclerosis. Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, 2015. pp. 219-234
@inbook{96068e4c2ac946c989d57b97bb533a7b,
title = "Amyotrophic lateral sclerosis",
abstract = "Motor neuron disorders encompass a group of neurodegenerative conditions in which the premature loss of motor neurons is the essential pathological feature. Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) in the United Kingdom, is the most common of these conditions. The major current therapeutic issues in ALS/MND are summarized in this chapter. The chapter examines whether pharmacological treatments prolong survival in patients with possible or definite ALS/MND. It explains how long-term mechanical ventilation (LTMV) affects survival and quality of life (QoL) in patients with ALS/MND with respiratory insufficiency. The chapter also examines how feeding gastrostomy improves nutritional state and probability of survival in patients with ALS/MND with bulbar involvement. The symptomatic treatments available for patients with ALS/MND are also covered in the chapter. The chapter finally analyzes whether multidisciplinary care (MDC) is an effective means of symptomatic and supportive management in patients with ALS/MND.",
keywords = "Amyotrophic lateral sclerosis, Feeding gastrostomy, Invasive assisted ventilation, Long-term mechanical ventilation, Motor neuron disease, Multidisciplinary care, Noninvasive positive pressure ventilation",
author = "O'Carroll, {Cumara B.} and Adcock, {Amelia K.} and Demaerschalk, {Bart M}",
year = "2015",
month = "12",
day = "11",
doi = "10.1002/9781119067344.ch21",
language = "English (US)",
isbn = "9780470657782",
pages = "219--234",
booktitle = "Evidence-Based Neurology",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Amyotrophic lateral sclerosis

AU - O'Carroll, Cumara B.

AU - Adcock, Amelia K.

AU - Demaerschalk, Bart M

PY - 2015/12/11

Y1 - 2015/12/11

N2 - Motor neuron disorders encompass a group of neurodegenerative conditions in which the premature loss of motor neurons is the essential pathological feature. Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) in the United Kingdom, is the most common of these conditions. The major current therapeutic issues in ALS/MND are summarized in this chapter. The chapter examines whether pharmacological treatments prolong survival in patients with possible or definite ALS/MND. It explains how long-term mechanical ventilation (LTMV) affects survival and quality of life (QoL) in patients with ALS/MND with respiratory insufficiency. The chapter also examines how feeding gastrostomy improves nutritional state and probability of survival in patients with ALS/MND with bulbar involvement. The symptomatic treatments available for patients with ALS/MND are also covered in the chapter. The chapter finally analyzes whether multidisciplinary care (MDC) is an effective means of symptomatic and supportive management in patients with ALS/MND.

AB - Motor neuron disorders encompass a group of neurodegenerative conditions in which the premature loss of motor neurons is the essential pathological feature. Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) in the United Kingdom, is the most common of these conditions. The major current therapeutic issues in ALS/MND are summarized in this chapter. The chapter examines whether pharmacological treatments prolong survival in patients with possible or definite ALS/MND. It explains how long-term mechanical ventilation (LTMV) affects survival and quality of life (QoL) in patients with ALS/MND with respiratory insufficiency. The chapter also examines how feeding gastrostomy improves nutritional state and probability of survival in patients with ALS/MND with bulbar involvement. The symptomatic treatments available for patients with ALS/MND are also covered in the chapter. The chapter finally analyzes whether multidisciplinary care (MDC) is an effective means of symptomatic and supportive management in patients with ALS/MND.

KW - Amyotrophic lateral sclerosis

KW - Feeding gastrostomy

KW - Invasive assisted ventilation

KW - Long-term mechanical ventilation

KW - Motor neuron disease

KW - Multidisciplinary care

KW - Noninvasive positive pressure ventilation

UR - http://www.scopus.com/inward/record.url?scp=85017992013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017992013&partnerID=8YFLogxK

U2 - 10.1002/9781119067344.ch21

DO - 10.1002/9781119067344.ch21

M3 - Chapter

AN - SCOPUS:85017992013

SN - 9780470657782

SP - 219

EP - 234

BT - Evidence-Based Neurology

PB - Wiley Blackwell

ER -